Biomarkers of free radical damage applications in experimental animals and in humans

Free Radical Biology and Medicine

Volumn 26, Issue 1-2, 1999, Pages 202-226

  De Zwart, Loeckie L ^a   Meerman, John H N ^a   Commandeur, Jan N M ^a   Vermeulen, Nico P E ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Aldehydic products; Alkanes; DNA hydroxylation; Free radical; Isoprostanes; Lipid peroxidation; Non invasive biomarkers; Protein oxidation

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALCOHOL; ALDEHYDE; ALKANE; ALPHA TOCOPHEROL; ANTIOXIDANT; BIOLOGICAL MARKER; CARBON TETRACHLORIDE; CAROTENOID; CATALASE; CYTOCHROME P450 REDUCTASE; DIQUAT; DNA; DOXORUBICIN; ENZYME; FREE RADICAL; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; LIPID PEROXIDE; MENADIONE; METAL; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PARAQUAT; POLYUNSATURATED FATTY ACID; PROTEIN; RETINOL; SELENIUM; SUPEROXIDE DISMUTASE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENZYME IMMUNOASSAY; GAS CHROMATOGRAPHY; HUMAN; HYDROXYLATION; LIPID PEROXIDATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKELESS TOBACCO;

ANIMALIA; NICOTIANA TABACUM;

EID: 0006198863     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00196-8     Document Type: Review

References (226)

1. Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. British Medical Bulletin. 49:1993;481-493.
2. Pryor W.A. Oxy-radicals and related species their formation, lifetimes, and reactions . Annu. Rev. Physiol. 48:1986;657-667.
3. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc. Soc. Exp. Biol. Med. 209:1995;104-111.
4. Henderson R.F., Bechtold W.E., Bond J.A., Sun J.D. The use of biological markers in toxicology. Crit. Rev. Toxicol. 20:1989;65-82.
5. Van Welie R.H.T., Van Sittart N.J., Van Dijck R., Vermeulen N.P.E. Mercapturic acid, protein, and DNA adducts as biomarkers of electrophilic chemicals. Crit. Rev. Toxicol. 22:1992;271-306.
6. De Rooij, B. M. Mercapturic acids in biological monitoring. Applications in industrial chemicals. Thesis 1:13-42; 1997.
7. Greim H., Csanády G., Filser J.G., Kreuzer P., Schwarz L., Wolff T., Werner S. Biomarkers as tools in human health risk assessment. Clin. Chem. 41:1995;1804-1808.
8. Lowry L.K. Role of biomarkers of exposure in the assessment of health risks. Toxicol. Lett. 77:1995;31-38.
9. Shigenaga M.K., Gimeno C.J., Ames B.N. Urinary 8-hydroxy-2′-deoxyguanosine as biological marker of in vivo oxidative DNA damage. Proc. Natl. Acad. Sci. USA. 86:1989;9697-9701.
10. Cundy K.C., Kohen R., Ames B.N. Determination of 8-hydroxyguanosine in human urine a possible assay for in vivo oxidative DNA damage . Basic Life Sci. 49:1988;479-482.
11. Kneepkens C.M., Lepage G., Roy C.C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17:1994;127-160.
12. Benedetti A., Casini A.F., Ferrali M., Comporti M. Effects of diffusible products of peroxidation of rat liver microsomal lipids. Biochem. J. 180:1979;303-312.
13. Esterbauer H. McBrien D.C.H., Slater T.F. Free radicals, lipid peroxidation and cancer. 1982;101-128 Academic Press, London.
14. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. USA. 87:1990;9383-9387.
15. Halliwell B., Kaur H., Ingelman-Sundberg M. Hydroxylation of salicylate as an assay for hydroxyl radicals a cautionary note . Free Radic. Biol. Med. 10:1991;439-441.
16. Nordmann R., Ribiére C., Touach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic. Biol. Med. 12:1992;219-240.
17. Recknagel R.O., Glendek E.A. Jr, Dolakk J.A., Waller R.L. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 43:1989;139-154.
18. Goeptar A.R., Scheerens H., Vermeulen N.P.E. Oxygen and xenobiotic reductase activities of cytochrome P450. Crit. Rev. Toxicol. 25:1995;25-65.
19. Umemura T., Sai K., Takagi A., Hasegawa R., Kurokawa Y. Oxidative DNA damage, lipid peroxidation and nephrotoxicity induced in the rat kidney after ferric nitrilotriacetate administration. Cancer Lett. 54:1990;95-100.
20. Sabapathy N.N. Quaternary ammonium compounds. Toxicology. 91:1994;93-98.
21. Rosen G.M., Hassett D.J., Yankaskas J.R., Cohen M.S. Detection of free radicals as a consequence of dog tracheal epithelial cellular xenobiotic metabolism. Xenobiotica. 19:1989;635-643.
22. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin the role of lipid peroxidation in cardiac toxicity and tumor response . Science. 197:1977;165-167.
23. Goeptar A.R., Te Koppele J.M., Lamme E.K., Piqué J.M., Vermeulen N.P.E. Cytochrome P450 2B1-mediated one-electron reduction of adriamycin a study with rat liver microsomes and purified enzymes . Mol. Pharmacol. 44:1993;1267-1277.
24. Knight J.A. Diseases related to oxygen-derived free radicals. Ann. Clin. Lab. Sci. 25:1995;111-121.
25. Gutteridgde J.M.C. Free radicals in disease processes A compilation of cause and consequence . Free Radic. Res. Comm. 19:1993;141-158.
26. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49:1993;577-587.
27. Adams J.D., Odunze I.N. Oxygen free radicals and Parkinson's disease. Free Radic. Biol. Med. 10:1991;161-169.
28. Dexter D.T., Wells F.R., Lees A.J., Agid Y., Agid F., Jenner P. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52:1989;1830-1836.
29. Sian J., Dexter D.T., Lees A.J., Daniel S., Agid Y., Javoy-Agid F. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
30. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
31. Hajimohammadreza I., Brammer M. Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci. Lett. 112:1990;333-337.
32. Zaman Z., Roche S., Fielden P., Frost P.G., Niriella D.C., Cayley A.C.D. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing. 21:1992;91-94.
33. Butterfield D.A. β-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem. Res. Toxicol. 10:1997;495-506.
34. Sayre L.M., Zagorski M.G., Surewicz W.K., Krafft G.A., Perry G. Mechanisms of neurotoxicity associated with amyloid β deposition and the role of free radicals in the pathogenesis of Alzheimer's disease A critical appraisal . Chem. Res. Toxicol. 10:1997;518-526.
35. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis. 23:1993;118-126.
36. Das D.K. Introduction. Ann. New York Acad. Sci. USA. 723:1994;xiii-xvi.
37. Riely C.A., Cohen G., Lieverman M. Ethane evolution A new index of lipid peroxidation . Science. 183:1974;208-212.
38. Frank H., Hintze T., Bimboes D., Remmer H. Monitoring lipid peroxidation by breath analysis Endogenous hydrocarbons and their metabolic elimination . Toxicol. Appl. Pharmacol. 56:1980;337-344.
39. Kivits G.A.A., Ganguli-Swarttouw M.A.C.R., Christ E.J. The composition of alkanes in exhaled air of rats as a result of lipid peroxidation in vivo. Effects of dietary fatty acids, vitamin E and selenium. Biochim. Biophys. Acta. 665:1981;559-570.
40. Zarling E.J., Mobarhan S., Bowen P., Sugerman S. Pulmonary pentane excretion increases with age in healthy subjects. Mech. Ageing Dev. 67:1993;141-147.
41. Pincemail J., Camus G., Roesgen A., Dreezen E., Bertrand Y., Lismonde M., Lamy M. Exercise induces pentane production and neutrophil activation in humans. Effect of propranolol. Eur. J. Appl. Physiol. Occup. Physiol. 61:1990;319-322.
42. Euler D.E., Dave S.J., Guo H.S. Effect of cigarette smoking on pentane excretion in alveolar breath. Clin. Chem. 42:1996;303-308.
43. Lettéron P., Duchatelle V., Berson A., Frometny B., Fisch C., Degott C., Benhamou J.P., Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut. 34:1993;409-414.
44. Refat M., Moore T.J., Kazui M., Risby T.H., Perman J.A., Schwarz K.B. Utility of breath ethane as a noninvasive biomarker of vitamin E status in children. Pediatr. Res. 30:1991;396-403.
45. Kazui M., Andreoni K.A., Williams G.M., Perler B.A., Bulkley G.B., Beattie C., Donham R.T., Sehnert S.S., Burdick J.F., Risby T.H. Visceral lipid peroxidation occurs at reperfusion after aortic cross-clamping. J. Vasc. Surg. 19:1994;473-477.
46. Lemoyne M., Van Gossum A., Kurian R., Jeejeebhoy K.N. Plasma vitamin E and selenium and breath pentane in home parenteral nutrition patients. Am. J. Clin. Nutr. 48:1988;1310-1315.
47. Kneepkens C.M.F., Ferreira C., Lepage G., Roy C.C. Hydrocarbon breath test in cystic fibrosis Evidence for increased lipid peroxidation . J. Pediatr. Gastroenterol. Nutr. 15:1992;344.
48. Kokoszka J., Nelson R.L., Swedler W.I., Skosey J., Abcarian H. Determination of inflammatory bowel disease activity by breath pentane analysis. Disp. Colon Rectum. 36:1993;597-601.
49. Humad S., Zarling E., Clapper M., Skosey J.L. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Radic. Res. Comm. 5:1988;101-106.
50. Weitz Z.W., Birnbaum A.J., Sobotka P.A., Zarling E.J., Skosey J.L. High breath pentane concentrations during acute myocardial infarction. Lancet. 337:1991;933-935.
51. Kovaleva E.S., Orlov O.N., Tsutsulkovskaia M.I., Vladimirova T.V. Lipid peroxidation in patients with schizophrenia. Zh. Nevropatol. Psikhiatr. Imeni S. S. Korsakova. 89:1989;108-110.
52. Toshniwal P.K., Zarling E.J. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem. Res. 17:1992;205-207.
53. Fokin V.F., Ponomareva N.V., Orlov O.N., Liderman R.R., Erin A.N. The relationship of the electrical reactions of the brain to lipid peroxidation processes in pathologic aging. Biull. Eksp. Biol. Med. 107:1989;682-684.
54. Sedghi S., Keshavarzian A., Klamut M., Eiznhamer D., Zarling E.J. Elevated breath ethane levels in active ulcerative colitis Evidence for excessive lipid peroxidation . Am. J. Gastroenterol. 89:1994;2217-2221.
55. Arterbery V.E., Pryor W.A., Jiang L., Sehnert S.S., Foster W.M., Abrams R.A., Williams J.R., Wharam M.D., Risby T.H. Breath ethane generation during clinical total body irradiation as a marker of oxygen-free-radical-mediated lipid peroxidation A case study . Free Radic. Biol. Med. 17:1994;569-576.
56. Drury J.A., Nycyk J.A., Cooke R.W.I. Pentane measurement in ventilated infants using a commercially available system. Free Radic. Biol. Med. 22:1997;895-900.
57. Olopade C.O., Zakkar M., Swedler W.I., Rubinstein I. Exhaled pentane levels in acute asthma. Chest. 111:1997;862-865.
58. Koster U., Albrecht D., Kapus H. Evidence for carbon tetrachloride- and ethanol-induced lipid peroxidation in vivo demonstrated by ethane production in mice and rats. Toxicol. Appl. Pharmacol. 41:1977;639-648.
59. Burk R.F., Lawrence, Lane J.K. Liver necrosis and lipid peroxidation in the rat as the result of paraquat and diquat administration. Effect of selenium deficiency. J. Clin. Invest. 65:1980;1024-1031.
60. Dresow B., Albert C., Zimmermann I., Nielsen P. Ethane exhalation and vitamin E/ubiquinol status as markers of lipid peroxidation in ferrocene iron-loaded rats. Hepatology. 21:1995;1099-1105.
61. Hotz P., Hoet P., Lauwerys R., Buchet J.-P. Development of a method to monitor low molecular mass hydrocarbons in exhaled breath of man Preliminary evaluation of its interest for detecting a lipoperoxidation process in vivo . Clin. Chim. Acta. 162:1987;303-310.
62. Van Gossum A., Kurian R., Whitwell J., Jeejeebhoy K.N. Decrease in lipid peroxidation measured by breath pentane output in normals after oral supplementation with vitamin E. Clin. Nutr. 7:1988;53-57.
63. Springfield J.R., Levitt M.D. Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. J. Lipid Res. 35:1994;1497-1504.
64. Mendis S., Sobotka P.A., Euler D.E. Pentane and isoprene in expired air from humans Gas-chromatographic analysis of single breath . Clin. Chem. 40:1994;1485-1488.
65. Zarling E.J., Clapper M. Technique for gas-chromatographic measurement of volatile alkanes from single breath samples. Clin. Chem. 33:1987;140-141.
66. Dillard C.J., Litov R.E., Savin W.M., Dumelin E.E., Tappel A.L. Effects of exercise, vitamin E, and ozone on pulmonary function and lipid peroxidation. J. Appl. Physiol. 45:1978;927-932.
67. Van Gossum A., Decuyper J. Breath alkanes as an index of lipid peroxidation. Eur. Respir. J. 2:1989;787-791.
68. Reiter R., Burk R.F. Effect of oxygen tension on the generation of alkanes and malondialdehyde by peroxidizing rat liver microsomes. Biochem. Pharmacol. 36:1987;925-929.
69. Burk R.F., Ludden T.M. Exhaled alkanes as indices of in vivo lipid peroxidation. Biochem. Pharmacol. 38:1989;1029-1032.
70. Allerheiligen S.R.B., Ludden T.M., Burk R.F. The pharmacokinetics of pentane, a by-products of lipid peroxidation. Drug Metab. Dispos. 15:1987;794-800.
71. Wade C.R., Van Rij A.M. In vivo lipid peroxidation in man as measured by the respiratory excretion of ethane, pentane, and other low-molecular-weight hydrocarbons. Anal. Biochem. 150:1985;1-7.
72. Hageman J.J., Bast A., Vermeulen N.P.E. Monitoring of oxidative free radical damage in vivo Analytical aspects . Chem. Biol. Interact. 82:1992;243-293.
73. Morita S., Snider M.T., Inada Y. Increased N-pentane excretion in humans a consequence of pulmonary oxygen exposure . Anesthesiology. 64:1986;730-733.
74. Knutson M.D., Viteri F.E. Concentrating breath samples using liquid nitrogen A reliable method for the simultaneous determination of ethane and pentane . Anal. Biochem. 242:1996;129-135.
75. Pryor W.A., Stanley H.P., Blair E. Autoxidation of polyunsaturated fatty acids. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids. 11:1976;370-379.
76. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. J. Clin. Invest. 90:1992;2502-2507.
77. 2-isoprostanes) are formed in situ on phospholipids. Proc. Natl. Acad. Sci. USA. 89:1992;10721-10725.
78. Morrow J.D., Harris T.M., Roberts L.J. II. Noncyclooxygenase oxidative formation of a series of novel prostaglandins Analytical ramifications for measurement of eicosanoids . Anal. Biochem. 184:1990;1-10.
79. Morrow J.D., Roberts L.J. II. Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Radic. Biol. Med. 10:1991;195-200.
80. Fröhlich J.C., Wilson T.W., Sweetman B.J., Smigel M., Nies A.S., Carr K., Watson J.T., Oates J.A. Urinary prostaglandins Identification and origin . J. Clin. Invest. 55:1975;763-770.
81. 2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268:1993;4161-4169.
82. 2a, is formed in vivo. Biochim. Biophys. Acta. 1210:1994;244-248.
83. 2a in humans. J. Biol. Chem. 271:1996;20617-20620.
84. Morrow J.D., Minton T.A., Mukundan C.R., Campbell M.D., Zackert W.E., Daniel V.C., Badr K.F., Blair I.A., Roberts L.J. II. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J. Biol. Chem. 269:1994;4317-4326.
85. DeWitt D.L. Prostaglandin endoperoxide synthase regulation of enzyme expression . Biochim. Biophys. Acta. 1083:1991;121-134.
86. Smith W.L., DeWitt D.L. Biochemistry of prostaglandin endoperoxide synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin. Nephrol. 15:1995;179-194.
87. 2a. J. Biol. Chem. 270:1995;9800-9808.
88. 2a, excretion in man. J. Pharmacol. Exp. Ther. 275:1995;94-100.
89. 2-isoprostane formation. Brit. J. Pharmacol. 118:1996;1285-1293.
90. Barden A., Beilin L.J., Ritchie J., Croft K.D., Walters B.N., Michael C.A. Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy. Clin. Sci. 91:1996;711-718.
91. 2a: a marker for lipid peroxidation after experimental brain injury. J. Neurosci. Meth. 68:133-136; 1996.©
92. 2a, a novel index of lipid peroxidation in vivo, by immuno affinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radic. Biol. Med. 20:1996;619-624.
93. Awad J.A., Burk R.F., Robertson L.J. II. Effect of selenium deficiency and glutathione-modulating agents on diquat toxicity and lipid peroxidation in rats. J. Pharmacol. Exp. Ther. 270:1994;858-864.
94. Burk R.F., Hill K.E., Awad J.A., Morrow J.D., Kato T., Cockell K.A., Reid Lyons P. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: Assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology. 21:1995;561-569.
95. Nanji A.A., Khwaja S., Tahan S.R., Hossein Sadrzadeh S.M. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J. Pharmacol. Exp. Ther. 269:1994;1280-1285.
96. 2-isoprostanes in bile A novel index of hepatic lipid peroxidation . Hepatology. 22:1995;962-968.
97. 2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J. Clin. Invest. 93:1994;998-1004.
98. 2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem. Biophys. Res. Comms. 200:1994;338-343.
99. 2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 348:1994;297-300.
100. 2a in the airways of human subjects. Am. J. Respir. Cell Mol. Biol. 9:1993;568-572.
101. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 332:1995;1198-1203.
102. 2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Lett. 368:1995;225-229.
103. 2-isoprostane and 4-hydroxynonenal excretion in human bile of patients with biliary tract and pancreatic disorders. Am. J. Gastroenterol. 92:1997;2069-2072.
104. Stein C.M., Tanner S.B., Awad J.A., Roberts L.J. II, Morrow J.D. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum. 39:1996;1146-1150.
105. Delanty, N.; Reilly, M. P.; Pratico, D.; Lawson, J. A.; McCarthy, J. F.; Wood, A. E.; Ohnishi, S. T.; Fitzgerald, D. J.; FitzGerald, G. A. Circulation 95:2492-2499; 1997.
106. 2 alpha in acute coronary angioplasty evidence for oxidant stress during coronary reperfusion in humans . Circulation. 96:1997;3314-3320.
107. 2+ stimulated lipid peroxidation in rat liver microsomes. Biochem. J. 208:1982;129-140.
108. Esterbauer H., Zollner H., Schaur R.J. Hydroxyalkenyls Cytotoxic products of lipid peroxidation . ISI Atlas Sci. Biochem. 1:1988;311-317.
109. Loidl-Stahlhofen A., Hannemann K., Spiteller G. Detection of short-chain α-hydroxyaldehydic compounds as pentafluorbenzyloxime derivatives in bovine liver. Chem. Phys. Lipids. 77:1995;113-119.
110. Ferrali M., Fulceri R., Benedetti A., Comporti M. Effects of carbonyl (4-hydroxyalkenyls) originating from the peroxidation of liver microsomal lipids on various microsomal enzyme activities of liver. Res. Commun. Chem. Pathol. Pharmacol. 30:1980;99-112.
111. Kautiainen A., Vaca C.E., Granath F. Studies on the relationship between hemoglobin and DNA adducts of malondialdehyde and their stability in vivo. Carcinogenesis. 14:1992;705-708.
112. Van der Vliet A., Bast A. Effect of oxidative stress on receptors and signal transmission. Chem. Biol. Interact. 85:1992;95-116.
113. Knight J.A., Pieper R.K., McClellan L. Specificity of the thiobarbituric acid reaction its use in studies of lipid peroxidation . Clin. Chem. 34:1988;2433-2438.
114. Draper H.H., Squires E.J., Mahmooch H., Wu J., Agarwal S., Hadley M. A Comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic. Biol. Med. 15:1993;353-363.
115. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth. Enzymol. 186:1990;421-431.
116. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9:1990;515-540.
117. Bird R.P., Silas S., Hung O., Hadley M., Draper H.H. Determination of malonaldehyde in biological materials by high-pressure liquid chromatography. Anal. Biochem. 128:1983;240-244.
118. Draper H.H., Polensek L., Hadley M., McGirr L.G. Urinary malondialdehyde as an indicator of lipid peroxidation in the diet and in the tissues. Lipids. 19:1984;836-843.
119. Petruska J.M., Leslie K.O., Mossman B.T. Enhanced lipid peroxidation in lung lavage of rats after inhalation of asbestos. Free Radic. Biol. Med. 11:1991;425-432.
120. Ballagi-Pordány G., Richter J., Koltai M., Aranyi Z., Pogátsa G., Schaper W. Is malondialdehyde a marker of the effect of oxygen free radicals in rat heart tissue? Basic Res. Cardiol. 86:1991;266-272.
121. Di Pierro D., Tavazzi B., Lazzarino G., Giardina B. Malondialdehyde is a biochemical marker of peroxidative damage in the isolated reperfused rat heart. Mol. Cell Biochem. 116:1992;193-196.
122. Vagnozzi R., Lazzarino G., Tavazzi B., Di Pierro D., Siragusa P., Giuffré R., Giardina B. Incomplete cerebral ischemia in the rat provokes increase of tissue and plasma malondialdehyde. Biol. Trace Element Res. 47:1995;241-246.
123. Lazzarino G., Tavazzi B., Di Pierro D., Vagnozzi R., Penco M., Giardina B. The relevance of malondialdehyde as a biochemical index of lipid peroxidation of postischemic tissues in the rat and human beings. Biol. Trace Element Res. 47:1995;165-170.
124. Pucheu S., Coudray C., Vanazetto G., Favier A., Machecourt J., De Leiris J. Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis Utility of assaying plasma malondialdehyde . Free Radic. Biol. Med. 19:1995;873-881.
125. Öhlin H., Gustavsson C.G., Pantev E., Thorvinger B., Öhlin A.-K. Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction. Br. Heart J. 73:1995;223-226.
126. Ekström T., Stahl A., Sigvardsson K., Högberg J. Lipid peroxidation in vivo monitored as ethane exhalation and malondialdehyde excretion in urine after oral administration of chloroform. Acta Pharmacol. Toxicol. 58:1986;289-296.
127. Selim S. Separation and quantitative determination of traces of carbonyl compounds as their 2,4-dinitrophenylhydrazones by high-pressure liquid chromatography. J. Chromatogr. 136:1977;271-277.
128. Shara M.A., Dickson P.H., Bagchi D., Stohs S.J. Excretion of formaldehyde, malondialdehyde, acetaldehyde and acetone in the urine of rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, paraquat, endrin and carbon tetrachloride. J. Chromatogr. B. 576:1992;221-233.
129. Bagchi D., Bagchi M., Hassoun E., Stohs S.J. Endrin-induced urinary excretion of formaldehyde, acetaldehyde, malondialdehyde and acetone in rats. Toxicology. 75:1992;81-89.
130. Bagchi D., Shara M.A., Bagchi M., Hassoun A., Stohs S.J. Time-dependent effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on serum and urine levels of malondialdehyde, formaldehyde, acetaldehyde, and acetone in rats. Toxicol. Appl. Pharmacol. 123:1993;83-88.
131. Akubue P.I., Stohs S.J. Effect of alachlor on the urinary excretion of malondialdehyde, formaldehyde, acetaldehyde, and acetone by rats. Bull. Environ. Contam. Toxicol. 50:1993;565-571.
132. Moser J., Bagchi D., Akubue P.I., Stohs S.J. Excretion of malondialdehyde, formaldehyde, acetaldehyde and acetone in the urine of rats following acute and chronic administration of ethanol. Alcohol and Alcoholism. 28:1993;287-295.
133. Bagchi D., Bagchi M., Hassoun E., Moser J., Stohs S.J. Effects of carbon tetrachloride, menadione, and paraquat on the urinary excretion of malondialdehyde, formaldehyde, acetaldehyde, and acetone in rats. J. Biochem. Toxicol. 8:1993;101-106.
134. Bagchi D., Bagchi M., Hassoun E., Stohs S.J. Detection of paraquat-induced in vivo lipid peroxidation by gas chromatography/mass spectrometry and high pressure liquid chromatography. J. Analyt. Toxicol. 17:1993;411-414.
135. Bagchi D., Bagchi M., Hassoun E., Stohs S.J. Smokeless tobacco induced increases in hepatic lipid peroxidation, DNA damage and excretion of urinary lipid metabolites. Int. J. Exp. Path. 75:1994;197-202.
136. Bagchi D., Bagchi M., Hassoun E., Kelly J., Stohs S.J. Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology. 95:1995;1-9.
137. Bagchi D., Bagchi M., Hassoun E., Stohs S.J. Cadmium-induced excretion of urinary lipid metabolites, DNA damage, glutathione depletion, and hepatic lipid peroxidation in Sprague-Dawley rats. Biol. Trace Element Res. 52:1996;143-154.
138. Bagchi D., Hassoun E.A., Bagchi M., Stohs S.J. Protective effects of antioxidants against endrin-induced hepatic lipid peroxidation, DNA damage, and excretion of urinary lipid metabolites. Free Radic. Biol. Med. 15:1993;217-222.
139. Dhanakoti S.N., Draper H.H. Response of urinary malondialdehyde to factors that stimulate lipid peroxidation. Lipids. 22:1987;643-646.
140. Winters D.K., Klejar L.A., Cederbaum A.I. Oxidation of glycerol to formaldehyde by rat liver microsomes. Biochem. Biophys. Res. Commun. 153:1988;612-617.
141. Tatum V.L., Changchit C., Chow C.K. Measurement of malondialdehyde by high performance liquid chromatography with fluorescence detection. Lipids. 25:1990;226-229.
142. Tomita M., Okuyama T., Kawai S. Determination of malonaldehyde in oxidized biological materials by high-performance liquid chromatography. J. Chromatogr. 515:1990;391-397.
143. Stashenko E.E., Ferreira M.C., Sequeda L.G., Martinez J.R., Wong J.W. Comparison of extraction methods an detection systems in the gas chromatographic analysis of volatile carbonyl compounds. J. Chromatogr. 779:1997;360-369.
144. Yeo H.C., Helbock H.J., Chyu D.W., Ames B.N. Assay of malondialdehyde in biological fluids by gas chromatography-mass spectrometry. Anal. Biochem. 220:1994;391-396.
145. Wong J.W., Ebeler S.E., Rivkah-Isseroff R., Shibamoto T. Analysis of malondialdehyde in biological samples by capillary gas chromatography. Anal. Biochem. 220:1994;73-81.
146. Tsuruta Y., Date Y., Tonogaito H., Sugihara N., Furuno K., Kohashi K. Determination of malondialdehyde by high-performance liquid chromatography using 4-(2-phthalimidyl)benzohydrazide as a pre-column fluorescent labeling reagent. Analyst. 119:1994;1047-1050.
147. Selley M.L. Determination of the lipid peroxidation product (E)-4-hydroxy-2-nonrenal in clinical samples by gas chromatography-negative-ion chemical ionization mass spectrometry of the O-pentafluorobenzyloxime. J. Chromatogr. 691:1997;263-268.
148. Thomas M.J., Robison T.W., Samuel M., Forman H.J. Detecting and identifying volatile aldehydes as dinitrophenylhydrazones using gas chromatography mass spectrometry. Free Radic. Biol. Med. 18:1995;553-557.
149. Luo X.P., Yazdanpanah M., Bhooi N., Lehotay D.C. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal. Biochem. 228:1995;294-298.
150. Stashenko E.E., Wong J.W., Mart'nez J.R., Mateus A., Shibamoto T. High-resolution gas chromatography with nitrogen-phosphorous detection of saturated volatile aldehydes derivatized with 2-hydrazinobenzothiazole. J. Chromatogr. 752:1996;209-216.
151. De Zwart L.L., Venhorst J., Groot M., Commandeur J.N.M., Hermanns R.C.A., Meerman J.H.N., Van Baar B.L.M., Vermeulen N.P.E. Simultaneous determination of eight lipid peroxidation degradation products in urine of rats treated with carbon tetrachloride using gas chromatography with electron-capture detection. J. Chromatogr. 694:1997;277-288.
152. De Zwart L.L., Hermanns R.C.A., Meerman J.H.N., Commandeur J.N.M., Salemink P.J.M., Vermeulen N.P.E. Evaluation of urinary biomarkers for radical-induced liver damage in rats treated with carbon tetrachloride. Toxicol. Appl. Pharmacol. 148:1998;71-82.
153. Hermanns R.C.A., De Zwart L.L., Salemink, P. J. M.; Commandeur J.N.M., Vermeulen N.P.E., Meerman J.H.N. Increased urinary excretion of biomarkers for oxidative kidney damage by ferric nitrilotriacetate. Toxicol. Sci. 43:1998;241-249.
154. Pryor W.A., Bermúdez E., Cueto R., Squadrito G.L. Detection of aldehdyes in bronchoalveolar lavage of rats exposed to ozone. Fund. Appl. Toxicol. 34:1996;148-156.
155. Nacítarhan S., Özben T., Tuncer N. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radic. Biol. Med. 19:1995;893-896.
156. Díaz-Vélez C.R., García-Castiñeiras S., Mendoza-Ramos E., Hernández-López E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am. Heart J. 131:1996;146-152.
157. Guichardant M., Valette-Talbi L., Cavadini C., Crozier G., Berger M. Malondialdehyde measurement in urine. J. Chromatogr. 655:1994;112-116.
158. Boyd N.F., McGuire V. Evidence of lipid peroxidation in premenopausal women with mammographic dysplasia. Cancer Lett. 50:1990;31-37.
159. Kosugi H., Enomoto H., Ishizuka Y., Kikugawa K. Variations in the level of urinary thiobarbituric acid reactant in healthy humans under different physiological conditions. Biol. Pharmaceut. Bull. 17:1994;1645-1650.
160. Michel P., Eggert W., Albrecht-Nebe H., Grune T. Increased lipid peroxidation in children with autoimmune diseases. Acta Paediatrica. 86:1997;609-612.
161. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
162. Wolff S.P., Jiang Z.Y., Hunt J.V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic. Biol. Med. 10:1991;339-352.
163. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K. Lipide peroxide level in plasma of diabetic patients. Biochem. Med. 21:1979;104-107.
164. Noberasco G., Odetti P., Boeri D., Maiello M., Adezati L. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed. Pharmacother. 45:1991;193-196.
165. Galou G., Tuelland A., Legras B., Maugendre D., Allanic H., Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin. Chim. Acta. 214:1993;227-234.
166. Griesmacher A., Kindhauser M., Andert S.E., Schreiner W., Toma C., Knoebl P., Pietschmann P., Prager R., Schnack C., Schernthaner G., Mueller M.M. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am. J. Med. 98:1995;469-475.
167. Özben T., Nacítarhan S., Tuncer N. Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria. Int. J. Clin. Lab. Res. 25:1995;162-164.
168. Kosugi H., Asano Y., Nagayama T., Beppu M., Kikugawa K. Urinary excretion of thiobarbituric acid reactive substances of healthy subjects supplemented with a high dose of d-alpha-tocopherol. Biol. Pharmaceut. Bull. 18:1995;1275-1278.
169. Ames B.N., Gold L.S. Endogenous mutagens and the causes of aging and cancer. Mutat. Res. 250:1991;3-16.
170. Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med. 10:1991;225-242.
171. Shigenaga M.K., Ames B.N. Assays for 8-hydroxy-2′-deoxyguanosine A biomarker of in vivo oxidative DNA damage . Free Radic. Biol. Med. 10:1991;211-216.
172. Kuchino Y., Mori F., Kasai H., Inoue H., Iwai S., Miura K., Ohtsuka E., Nishimura S. Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature. 327:1987;77-79.
173. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation damaged base 8-oxodG. Nature. 349:1991;431-434.
174. Cheng K.C., Cahill D.S., Kasai H., Nishimura S., Loeb L.A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions. J. Biol. Chem. 267:1992;166-172.
175. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450.
176. Fraga C.G., Shigenaga M.K., Park J.-W., Degan P., Ames B.N. Oxidative damage to DNA during aging 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine . Proc. Natl. Acad. Sci. USA. 87:1990;4533-4537.
177. Ames B.N., Saul R. Genetic toxicology of environmental chemicals. 1985;1-16 Liss, New York.
178. Hollstein M.C., Brooks P., Linn S., Ames B.N. Hydroxymethyluracil DNA glycosylate in mammalian cells. Proc. Natl. Acad. Sci. USA. 81:1984;4003-4007.
179. Cathcart R., Schwiers E., Saul R.L., Ames B.N. Thymine glycol and thymidine glycol in human and rat urine; A possible assay for oxidative DNA damage. Proc. Natl. Acad. Sci. USA. 81:1984;5633-5637.
180. Adelman R., Saul R.L., Ames B.N. Oxidative damage to DNA Relation to species metabolic rate and life span . Proc. Natl. Acad. Sci. USA. 85:1988;2706-2708.
181. Floyd R.A., Watson J.J., Harris J., West M., Wong P.K. Formation of 8-hydroxydeoxyguanosine, hydroxyl free radical adduct of DNA in granulocytes exposed to the tumor promoter, tetradeconylphorbolacetate. Biochem. Biophys. Res. Comm. 137:1986;841-846.
182. Floyd R.A., Watson J.J., Wong P.K., Altmiller D.H., Rickard R.C. Hydroxyl free radical adduct of deoxyguanosine Sensitive detection and mechanisms of formation . Free Radic. Res. Comms. 1:1986;163-172.
183. Richter C., Park J.-W., Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA. 85:1988;6465-6467.
184. Umemura T., Sai K., Takagi A., Hasegawa R., Kurokawa Y. Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis. 11:1990;345-347.
185. Kiyosawa H., Suko M., Okudaira H., Murata K., Miyamoto T., Chung M.-H., Kasai H., Nishimura S. Cigarette smoking induced formation of 8-hydroxydeoxyguanosine, one of the oxidative DNA damages in human peripheral leukocytes. Free Radic. Res. Comm. 11:1990;23-27.
186. Degan P., Shigenaga M.K., Park E.-M., Alperin P.E., Ames B.N. Immuno affinity isolation of urinary 8-hydroxy-2′-deoxyguanosine and 8-hydroxyguanine and quantitation of 8-hydroxy-2′-deoxyguanosine in DNA by polyclonal antibodies. Carcinogenesis. 12:1991;865-871.
187. Loft S., Vistisen K., Ewertz M., Tjønneland A., Overvad K., Poulsen H.E. Oxidative DNA-damage estimated by 8-hydroxydeoxyguanosine excretion in man Influence of smoking, gender and body mass index . Carcinogenesis. 13:1992;2241-2247.
188. Loft S., Fischer-Nielsen A., Jeding I.B., Vistisen K., Poulsen H.E. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health. 40:1993;391-404.
189. Inoue T., Mu Z., Sumikawa K., Adachi K., Okochi T. Effect of physical exercise on the content of 8-hydroxydeoxyguanosine in nuclear DNA prepared from human lymphocytes. Jpn. J. Cancer Res. 84:1993;720-725.
190. Denda A., Tang Q., Endoh T., Tsujiuchi T., Horiguchi K., Noguchi O., Mizumoto Y., Nakae D., Konishi Y. Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis. 15:1994;1279-1283.
191. Muñiz P., Valls V., Perez-Broseta C., Iradi A., Climent J.V., Oliva M.R., Sáez G.T. The role of 8-hydroxy-2′-deoxyguanosine in rifamycin-induced DNA damage. Free Radic. Biol. Med. 18:1995;747-755.
192. Hattori Y., Nishigori C., Tanaka T., Uchida K., Nikaido O., Osawa T., Hiaia H., Imamura S., Toyokuni S. 8-Hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure. J. Invest. Dermatol. 107:1997;733-737.
193. Lagorio S., Tagesson C., Forastiere F., Iavarone I., Axelson O., Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occupat. Environ. Med. 51:1994;739-743.
194. Tagesson C., Källberg M., Klintenberg C., Starkhammar H. Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography A powerful technique for assaying in vivo oxidative DNA damage in cancer patients . Eur. J. Cancer. 31:1995;934-940.
195. Shen H.M., Chia S.E., Ni Z.Y., New A.L., Lee B.L., Ong C.N. Detection of oxidative DNA damage in human sperm and the association with cigarette smoking. Repr. Toxicol. 11:1997;675-680.
196. Takeuchi T., Morimot K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis. 14:1993;1115-1120.
197. Degan P., Bonassi S., De Caterina M., Korkina L.G., Pinto L., Scopacasa F., Zatterale A., Calzone R., Pagano G. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis. 16:1995;735-741.
198. Bashir S., Harris G., Denman M.A., Blake D.R., Winyard P.G. Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases. Ann. Rheum. Dis. 52:1993;659-666.
199. Leinone J., Lehtimaki T., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Laippala P., Rantalaiho V., Wirta O., Pasternack A., Alho H. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett. 417:1997;150-152.
200. Chapman M.L., Rubin B.R., Gracy R.W. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J. Rheumatol. 16:1989;15-19.
201. Smith C.D., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 88:1991;347-353.
202. Gladstone I.M., Levine R.L. Oxidation of proteins in neonatal lungs. Pediatrics. 93:1994;764-768.
203. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E.R., Mizuno Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA. 93:1996;2696-2701.
204. Uchida K., Toyokuni S., Kishikawa S., Oda H., Hiaia H., Stadtman E.R. Michael addition-type 4-hydroxy-2-nonrenal adducts in modified low-density lipoproteins markers for atherosclerosis . Biochemistry. 33:1994;12487-12494.
205. Huggins T.G., Wells-Knecht M.C., Detorie N.A., Baynes J.W., Thorpe S.R. Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation. J. Biol. Chem. 17:1993;12341-12347.
206. Heinecke J., Li W., Daehnke H.L., Goldstein J.A. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 25:1993;4069-4077.
207. Giulivi C., Davies K.J.A. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. J. Biol Chem. 12:1993;8752-8759.
208. 3H] hydride reduction. J. Biol. Chem. 22:1991;14446-14450.
209. Witko-Sarsat V., Friedlander M., Capeillére-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1966;1304-1313.
210. Daneshvar B., Frandsen H., Autrup H., Dragsted L.O. g-Glutamyl semialdehyde and 2-amino-adipic semialdehyde: Biomarkers of oxidative damage to protein. Biomarkers. 2:1997;117-123.
211. Dohlman A.W., Black H.R., Royall J.A. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am. Rev. Respir. Dis. 148:1993;955-960.
212. Varma S.D., Devamanoharan P.S. Excretion of hydrogen peroxide in human urine. Free Radic. Res. Comms. 8:1990;73-78.
213. Dekhuijzen P.N., Aben K.K., Dekker I., Aarts L.P., Wielders P.L., van Herwaarden C.L., Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 154:1996;813-816.
214. Sznajder J.I., Fraiman A., Hall J.B., Sanders W., Schmidt G., Crawford G., Nahum A., Factor P., Wood L.D. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure. Chest. 96:1989;606-612.
215. Grootveld M., Halliwell B. 2,3-Dihydroxybenzoic acid is a product of human aspirin metabolism. Biochem. Pharmacol. 37:1988;271-280.
216. Tubaro M., Cavallo G., Pensa M.A., Natale E., Ricci R., Milazzotto F., Tubaro E. Demonstration of the formation of hydroxyl radicals in acute myocardial infarction in man using salicylate as probe. Cardiology. 80:1992;246-251.
217. Ghiselli A., Laurenti L., De Mattia G., Maiani G., Ferro-Luzzi A. Salicilate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic. Biol. Med. 13:1992;621-626.
218. Coudray C., Talla M., Martin S., Fatôme M., Favier A. High-performance liquid chromatography-electrochemical determination of salicylate hydroxylation products as an in vivo marker of oxidative stress. Anal. Biochem. 227:1995;101-111.
219. Nair U.J., Nair J., Friesen M.D., Bartsch H., Ohshima H. Ortho- and meta-tyrosine formation from phenylalanine in human saliva as a marker of hydroxyl radical generation during betel quid chewing. Carcinogenesis. 16:1995;195-1198.
220. Lubec G., Widness J.A., Hayde M., Menzel D., Pollak A. Hydroxyl radical generation in oxygen-treated infants. Pediatrics. 100:1997;700-704.
221. Young I.S., Trouton T.G., Torney J.J., McMaster D., Callender M.E., Trimble E.R. Antioxidant status and lipid peroxidation in hereditary hemochromatosis. Free Radic. Biol. Med. 16:1994;393-397.
222. Ceballos-Picot I., Witko-Sarsat V., Merad-Boudia M., Nguyen A.T., Thévenin M., Joudon M.C., Zingraff J., Verger C., Jungers P., Descamps-Latscha B. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic. Biol. Med. 21:1996;845-853.
223. Sundaram R.K., Bhaskar A., Vijayalingam S., Viswanathan M., Mohan R., Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Sci. 90:1996;255-260.
224. Faure H., Coudray C., Mousseau M., Ducros V., Douki T., Bianchini F., Cadet J., Favier A. 5-Hydroxymethyluracil excretion, plasma TBARS and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic. Biol. Med. 20:1996;979-983.
225. Tyrrell R.M., Applegate L.A., Tromvoukis Y. The proximal promoter region of the human heme oxygenase gene contains elements involved in stimulation of transcriptional activity by a variety of agents including oxidants. Carcinogenesis. 14:1993;761-765.
226. Treina G., Scaletta C., Fourtanier A., Seite S., Frenk E., Applegate L.A. Expression of intercellular adhesion molecule-1 in UVA-irradiated human skin cells in vitro and in vivo. Br. J. Dermatol. 135:1996;241-247.